Divi's Laboratories Ltd. (DIVI)

Currency in INR
6,361.50
-234.00(-3.55%)
Closed·
DIVI Scorecard
Full Analysis
Trading at a high earnings multiple
Earnings results expected in 4 days
Fair Value
Day's Range
6,335.506,598.00
52 wk Range
4,615.557,071.50
Key Statistics
Bid/Ask
6,361.50 / 6,419.00
Prev. Close
6,595.5
Open
6,598
Day's Range
6,335.5-6,598
52 wk Range
4,615.55-7,071.5
Volume
467.22K
Average Volume (3m)
431.55K
1-Year Change
29.35%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
DIVI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
6,459.59
Upside
+1.54%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high P/E ratio relative to near-term earnings growth

Divi's Laboratories Ltd. News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Divi's Laboratories Ltd. Company Profile

Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as lutein and vitamins used in the food, beverage, dietary supplement, pet food, and feed industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India.

Employees
10542
Market
India

Compare DIVI to Peers and Sector

Metrics to compare
DIVI
Peers
Sector
Relationship
P/E Ratio
77.1x32.4x−0.5x
PEG Ratio
2.090.790.00
Price/Book
11.3x3.0x2.6x
Price / LTM Sales
18.0x3.3x3.2x
Upside (Analyst Target)
3.4%8.8%45.7%
Fair Value Upside
Unlock−5.2%8.6%Unlock

Analyst Ratings

11 Buy
7 Hold
10 Sell
Ratings:
28 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 6,459.59
(+1.54% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 82.53%
Dividend Yield
0.47%
Industry Median 0.73%
Annualised payout
30.00
Paid annually
5-Years Growth
+13.40%
Growth Streak

Earnings

Latest Release
May 17, 2025
EPS / Forecast
24.90 / 20.67
Revenue / Forecast
25.85B / 25.78B
EPS Revisions
Last 90 days

DIVI Income Statement

People Also Watch

377.20
BAJE
-1.54%
1,992.40
KTKM
+0.70%
5,528.00
EICH
+1.09%
1,438.80
TEML
-1.70%
1,502.80
CIPL
-3.33%

FAQ

What Stock Exchange Does Divi's Labs Trade On?

Divi's Labs is listed and trades on the India National Stock Exchange stock exchange.

What Is the Stock Symbol for Divi's Labs?

The stock symbol for Divi's Labs is "DIVI."

What Is the Divi's Labs Market Cap?

As of today, Divi's Labs market cap is 1.69T.

What Is Divi's Labs's Earnings Per Share (TTM)?

The Divi's Labs EPS (TTM) is 82.53.

When Is the Next Divi's Labs Earnings Date?

Divi's Labs will release its next earnings report on 05 Aug 2025.

From a Technical Analysis Perspective, Is DIVI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Divi's Labs Stock Split?

Divi's Labs has split 3 times.

How Many Employees Does Divi's Labs Have?

Divi's Labs has 10542 employees.

What is the current trading status of Divi's Labs (DIVI)?

As of 02 Aug 2025, Divi's Labs (DIVI) is trading at a price of 6,361.50, with a previous close of 6,595.50. The stock has fluctuated within a day range of 6,335.50 to 6,598.00, while its 52-week range spans from 4,615.55 to 7,071.50.

What Is Divi's Labs (DIVI) Price Target According to Analysts?

The average 12-month price target for Divi's Labs is INR6459.58621, with a high estimate of INR7900 and a low estimate of INR4381. 11 analysts recommend buying the stock, while 10 suggest selling, leading to an overall rating of Neutral. The stock has an +1.54% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.